Christopher Raymond
Analyst
Raymond James
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Christopher Raymond
Christopher Raymond is recorded as Analyst at Raymond James and Analyst at Piper Sandler. Christopher Raymond has spoken on 2 earnings calls across 2 companies, most recently for Lexeo Therapeutics, Inc. on September 22, 2026. Those appearances were for Lexeo Therapeutics, Inc. (LXEO) and Biomarin Pharmaceutical Inc (BMRN). The companies whose calls Christopher Raymond spoke on are classified in the Healthcare sector.
Christopher Raymond on recent calls
“I just want to dig in a little bit more to the mechanism, I guess, to cross over from Clarity to Sunrise. I think I heard you say that you've got double-digit patients enrolled or identified now for Clarity.”
“Just on the ERT business, you guys have, I think, for some time now talked about being able to reflect, you know, sort of the demand higher on harmonizing diagnostic protocols, I think, across all geographies.”
Affiliation history
-
Raymond James
Analyst
Source not stated
Current -
Piper Sandler
Analyst
Source not stated
Current